References: Zhang S, Lu G, Qi J, Li Y, Zhang Z, Zhang B, Fan Z, Yan J, Gao GF. Competition of cell adhesion and immune recognition: insights into the interaction between CRTAM and nectin-like 2. Structure. 2013 Aug 6;21(8):1430-9.
Dessarthe B, Thedrez A, Latouche JB, Cabillic F, Drouet A, Daniel P, de La Pintiere CT, Catros V, Toutirais O. CRTAM receptor engagement by Necl-2 on tumor cells triggers cell death of activated Vg9Vd2 T cells. J Immunol. 2013 May 1;190(9):4868-76.
Patino-Lopez G, Hevezi P, Lee J, Willhite D, Verge GM, Lechner SM, Ortiz-Navarrete V, Zlotnik A. Human class-I restricted T cell associated molecule is highly expressed in the cerebellum and is a marker for activated NKT and CD8+ T lymphocytes. J Neuroimmunol. 2006 Feb;171(1-2):145-55.
Boles KS, Barchet W, Diacovo T, Cella M, Colonna M. The tumor suppressor TSLC1/NECL-2 triggers NK-cell and CD8+ T-cell responses through the cell-surface receptor CRTAM. Blood. 2005 Aug 1;106(3):779-86. (Cr24.1 FC PubMed)